Gene panel predicts neoadjuvant chemoimmunotherapy response and benefit from immunotherapy in HER2-negative breast cancer.

J Immunother Cancer · 2024 · PMC11337705 · PMID 39134345

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In cohort A grouped by the median values of the other markers, the NACT+pembro arm exhibited an increasing trend in pCR rates than the NACT arm in both high and low groups ( online supplemental figure S12B–E ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.